Pfizer
-
Pfizer and Novo Nordisk rebuked over pharma payments
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.